Lung Cancer Europe/LinkedIn
Jun 23, 2025, 14:54
New Lancet review highlights the surge in cancer vaccine research – Lung Cancer Europe
Lung Cancer Europe shared a post on LinkedIn:
“New Lancet review highlights the surge in cancer vaccine research. 200+ trials now running globally. Lung cancer is part of this emerging field – but still under-represented compared to melanoma, breast and others.
We need stronger inclusion:
more global lung cancer vaccine trials
wider access across European countries
diverse patient populations included
Every cancer. Every patient.”
Title: Cancer vaccines and the future of immunotherapy
Authors: Orrin Pail, Matthew J Lin, Theodora Anagnostou, Brian D Brown, Joshua D Brody
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 14:50
Jun 26, 2025, 14:20
Jun 26, 2025, 13:31